| 翻訳と辞書 | Durata Therapeutics| Durata Therapeutics  : ウィキペディア英語版 | 
 Durata Therapeutics, established in 2009 in Morristown, New Jersey, is a clinical development stage pharmaceutical company which focuses on the treatment of infectious diseases.  The company acquired dalbavancin, a long-acting semisynthetic lipoglycopeptide antibiotic, from Pfizer in December 2009.〔(Durata Therapeutics Acquires Pfizer’s Subsidiary that Develops Antibiotics. ) GEN News Highlights: Dec 21, 2009.〕 Durata has initiated two Phase III studies of dalbavancin for intravenous (IV) treatment of acute bacterial skin and skin structure infections.〔(Durata Begins Dalbavancin Study Enrollment. ) Drug Discovery & Development - October 05, 2011.〕  In 2012, the company moved its global headquarters from Morristown to Chicago in a deal with $2 million in tax credits. In October of 2014 Durata was acquired by Actavis for about $675 million.〔http://www.fiercebiotech.com/story/actavis-snaps-durata-newly-approved-antibiotic-675m-buyout/2014-10-06〕
 ==References==
 
 
 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』
 ■ウィキペディアで「Durata Therapeutics」の詳細全文を読む
 
 
 
 スポンサード リンク
 
 | 翻訳と辞書 : 翻訳のためのインターネットリソース | 
 | Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
 
 | 
 |